Internal Control · 2024
In this section8 topics
- Internal Control — Board Opinion1 item
- Adequacy & Appropriateness of the Internal Control System1 item
- Internal Control Deficiencies1 item
- Audit Committee & Auditor Observations2 items
- Opinion on the Head of Internal Audit2 items
- Appointment, Discharge & Transfer of the Head of Internal Audit2 items
- Related Party Transactions1 item
- Counterparties & Transactions3 items
Internal Control — Board Opinion
Summary of the Board's Opinion on Internal Control
The Board of Directors and management have placed importance on internal control and risk management as key mechanisms to assure management in assessing the internal control system and help mitigate business risks for efficient operations, with appropriate resource allocation and achievement of the set goals.
The Board of Directors has assigned the Audit Committee, which is composed of independent directors, with the duties and responsibilities to review the financial reports for completeness, accuracy, reliability, timeliness, and adequate disclosure of information, as well as to assess the internal control system, review the appropriateness and effectiveness of the internal control system established by the Company's management. This is to ensure that the Company has an adequate internal control system to manage business risks, safeguard the Company's assets from loss or unauthorized use, and ensure that the Company's personnel comply with relevant laws and regulations. In addition, the Audit Committee considers the independence of the internal audit function, approves the qualifications, suitability, and adequacy of personnel in the unit, and approves the appointment, transfer, and termination of the head of internal audit.
The Audit Committee has reviewed the appropriateness and effectiveness of the internal control and internal audit systems by considering them jointly with the internal auditors and reporting to the Board of Directors on significant matters. In the past year, the Audit Committee has expressed its opinions and provided suggestions to management on important matters. In addition, there was a meeting with the external auditor, EY Company Limited, the auditor of the 2023 financial statements, who expressed the opinion that the overall internal control system of the Company is at a satisfactory level and no deficiencies were found that would have a material effect on the auditor's opinion on the financial statements.
At the Board of Directors' Meeting No. 12/2567 held on December 11, 2567 The Board of Directors has assessed the adequacy of the internal control system, which is assessed annually, following the guidelines of the Securities and Exchange Commission (SEC). This assessment is based on the framework of The Committee of Sponsoring Organizations of the Treadway Commission (COSO), which consists of 5 main components of the internal control system:
(1) Control Environment
(2) Risk Assessment
(3) Control Activities
(4) Information & Communication System
(5) Monitoring Activities
The Board of Directors is of the view that the Company has adequate and appropriate internal control systems in all 5 components. The Board is confident that the Company has appropriate and sufficient internal control systems to manage various risks and ensure that the Company's operations are in accordance with the determined standards, as well as support the Company in achieving its business objectives effectively and sustainably.
Adequacy & Appropriateness of the Internal Control System
Internal Control Framework Used
| Framework | Detail |
|---|---|
| The Committee of Sponsoring Organizations of the Treadway Commission (COSO) | The company has a sufficient and appropriate internal control system based on the principles set by The Committee of Sponsoring Organizations of the Treadway Commission (COSO), which consists of 5 core components that work together effectively to enhance the quality of internal control and support the company's operations to be efficient and transparent, with the following details: • Control Environment The company has created an environment that promotes appropriate internal control by setting ethical standards, clear accountability from top management, and fostering a corporate culture of transparency and accountability in operations. All of these are important foundations that help the internal control system to be stable and achieve organizational objectives. • Risk Assessment The company conducts regular risk assessments, considering various risks that may affect the achievement of organizational goals, whether they are business risks within the organization or risks from external factors that may affect operations. This risk assessment will enable the company to effectively manage potential problems or risks. • Control Activities The company has established strict and appropriate control measures to mitigate risks and prevent errors that may arise from various processes within the organization. These controls cover operations, finance, and compliance to ensure that operations are in accordance with established policies and plans. • Information & Communication The company has an effective information system for managing and communicating important information both within and outside the organization. The information received will be delivered to relevant individuals accurately, timely, and completely, which aids in decision-making with accurate and readily available information at all levels of the organization. • Monitoring Activities The company continuously monitors and evaluates its operations to ensure that internal controls are effective and aligned with established objectives. This monitoring enables the company to assess the effectiveness of the internal control system and make improvements as needed. |
Internal Control Deficiencies
Number of Deficiencies
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of internal control system deficiencies (cases) | 0 | 0 | 0 |
Audit Committee & Auditor Observations
Audit Committee's Opinion Differs from the Board's
No
Auditor Has Observations on Internal Control
No
Opinion on the Head of Internal Audit
Head of Internal Audit
3159
Audit Committee's Opinion on the Head of Internal Audit
The appointment of an internal employee as the Head of Internal Audit is a practice that can promote the effectiveness of internal audit in many aspects. The incumbent possesses knowledge and understanding of the company's business and operations, which can lead to appropriate audits as they can identify potential problems or risks associated with internal operations accurately.
However, the Audit Committee recognizes the importance of maintaining independence and transparency in the operations of the internal audit function. It has established clear oversight to ensure that the work of the Head of Internal Audit is effective and free from external factors or from senior management that may affect the impartiality of the operations.
The Audit Committee also places importance on continuously enhancing the knowledge and skills of personnel responsible for internal audit. This ensures they can adapt and respond to business changes and relevant regulations promptly. Overall, the Audit Committee believes that having an internal employee as the Head of Internal Audit can be advantageous in conducting audits with an understanding and familiarity with the organization's context. However, it is essential to strictly maintain the independence of the internal audit function for the utmost benefit of the organization.
Appointment, Discharge & Transfer of the Head of Internal Audit
Requires Audit Committee Approval
Yes
Description
The appointment, removal, and transfer of the Head of Internal Audit must be conducted in accordance with established procedures and regulations to ensure transparency, independence, and suitability within the context of the company's operations. The guidelines are as follows:
• Appointment of the Head of Internal Audit
The appointment of the Head of Internal Audit must be approved by the Audit Committee, considering the qualifications and experience relevant to internal audit, including risk management skills and the enforcement of internal control measures. The appointee must be independent in their operations and not be in a position of conflict of interest with the management or other units within the company. The Audit Committee is responsible for selecting and nominating suitable candidates for this position.
• Removal of the Head of Internal Audit
The removal of the Head of Internal Audit must be based on clear and justifiable reasons, such as failure to perform duties as expected or deficiencies that impact internal audit or the company's operations. The removal must be considered and approved by the Audit Committee, taking into account the appropriateness and potential impact on the company's internal control. In the event of removal, a replacement must be appointed to ensure the continuity of the Internal Audit function. The transfer of the Head of Internal Audit
• Transfer of the Head of Internal Audit
It must be considered based on the need to improve operations or enhance the effectiveness of internal audit in line with the company's strategies or requirements. The transfer must be approved by the Audit Committee, taking into account the potential impact on internal audit processes and the company's operations. The transfer must prioritize maintaining the independence and transparency of the internal audit function.
Overall, the process of appointing, removing, and transferring the Head of Internal Audit must be carried out with caution and transparent procedures to maintain confidence in the company's internal control system. The Audit Committee will oversee the implementation in accordance with the established regulations to ensure the independence and effectiveness of the Internal Audit function.
Related Party Transactions
Has Related Party Transactions
Yes
Counterparties & Transactions
Monetary Unit
1000000
Counterparties with Potential Conflicts
| Name | Person / Juristic Person | Type of Business | Nature of Relationship | As of Date (YYYY-MM-DD) |
|---|---|---|---|---|
| Saivichai Development Company Limited | Juristic Person | Private Hospital Business | 1. It is a subsidiary in which the Company holds 99.43 % of the paid-up capital. 2. Both companies have the same directors: Assoc. Prof. Vichai Vanadurongwan, M.D., Ph.D.,FIMS, Asst. Prof.Saisunee Vanadurongwan,M.D. and Vilawan Vanadurongwan, Ms. 3. Both companies have the same group of shareholders with control, namely the Vanadurongwan family group. The Vanadurongwan family group holds 52.23 % of the Company's paid-up capital as of December 31, 2024, and indirectly holds 52.53 % of the paid-up capital of Saivichai through the Company as of the same date. | 2024-12-31T00:00 |
| Srisakhon vejavivat Company Limited. | Juristic Person | Private Hospital Business | 1. It is a subsidiary in which the Company holds 99.56 % of the paid-up capital. 2. Both companies have the same directors, namely Assoc. Prof. Vichai Vanadurongwan, M.D., Ph.D.,FIMS and Asst. Prof.Saisunee Vanadurongwan,M.D. and Mongkon Wanitphakdeedecha, M.D., and Prut Rojmahamongkol, Mr. 3. Both companies have the same group of controlling shareholders, namely the Vanadurongwan Group. The Vanadurongwan Group holds 52.23 % of the Company's paid-up capital as of December 31, 2024, and indirectly holds 52.46 % of Srisakorn's paid-up capital through the Company as of the same date. | 2024-12-31T00:00 |
| Bangkok Orthopedic Hospital Company Limited | Juristic Person | Private Hospital Business | 1. It is a subsidiary in which the Company holds 100.00 % of the paid-up capital. 2. Both companies have joint directors, namely Asst. Prof.Saisunee Vanadurongwan, M.D., Mongkon Wanitphakdeedecha, M.D., and Prut Rojmahamongkol, Mr. 3. Both companies have the same group of shareholders with control, namely the Vanadurongwan Group. The Vanadurongwan Group holds direct shares in the Company, representing 52.23 % of the Company's paid-up capital as of December 31, 2024, and indirectly holds shares in Yaek FaiChai through the Company, representing 52.23 %of Yaek FaiChai s paid-up capital on the same date. | 2024-12-31T00:00 |
| Srivichai Vocational School Company Limited | Juristic Person | The business provides training and education to external individuals to prepare them for roles as nursing assistants. | 1. It is a subsidiary in which the Company holds 99.98 %of the paid-up capital. (Srivichai School was registered on December 27, 2010, to operate a business of providing training and education to outsiders to prepare personnel in the field of nursing assistants.) 2. Both companies have the same group of shareholders with control, namely the Vanadurongwan Group. The Vanadurongwan Group directly holds 52.23 % of the Company's paid-up capital as of December 31, 2024, and indirectly holds 52.24 % of Srivichai School's paid-up capital through the Company as of the same date. | 2024-12-31T00:00 |
| Watthana Vejvivat Company Limited | Juristic Person | Private Hospital Business | 1. It is a subsidiary in which the Company holds 100.00 % of the registered capital. 2. Both companies have directors in common, namely, Asst. Prof. Dr. Bavornrat Vanadurongwan and Dr. Mongkon Wanitphakdeedecha. 3. Both companies have the same group of shareholders with control, namely, the Vandurongwan family group. The Vanadurongwan family group directly holds 52.23 % of the Company's paid-up capital as of December 31, 2024, and indirectly held shares through the Company, accounting for 52.23 % of Srisakorn's paid-up capital on the same day. | 2024-12-31T00:00 |
| Sriwichai Savings Cooperative | Juristic Person | A credit union established to support the savings of employees within the Vichaiyut Hospital Group. | 1. Srivichai Savings Cooperative is a savings cooperative established to promote savings among employees within the Vichaivej Hospital Group, consisting of the Company, Saivichai, Srisakorn, Battery Torch Factory, and Srivichai Hotel. 2. The Board of Directors, including Prof. Dr. Vichai Vanadurongwan and Asst. Prof. Dr. Saisunee Vanadurongwan, serve as Honorary Advisors to the Srivichai Savings Cooperative. | 2024-12-31T00:00 |
| Assoc. Prof. Dr. Nop Wichai Vandurongvan | Person | 1. Holds the position of Chairman of the Board of Directors of the Company, Saivichai, and Srisakhon. 2. Is a shareholder of the Company. Assoc. Prof. Dr. Vichai and persons under Section 258 hold shares, both directly and indirectly, in the Company, representing 1.51 % of the total voting shares of each company. | 2024-12-31T00:00 | |
| Assoc. Prof. Dr. Saysunee Vongdrungrit | Person | Holding the positions of Chief Executive Officer and Vice Chairman of the Board of Directors of the Company, Saivichai Srisakorn and Director of Yaek Faichai. | 2024-12-31T00:00 | |
| Ms. Willawan Vandurongvan | Person | 1. Serves as a member of the Remuneration and Nomination Committee, Chairperson of the Finance and Investment Planning Working Committee, and Director of the Company and its subsidiaries. 2. Younger sister of Assoc. Prof. Dr. Vichai Vanadurongwan | 2024-12-31T00:00 | |
| Dr. Pongsak Watthana | Person | 1. Holding positions as advisor to the Board of Directors and Chairman of the Board of Directors of Srivichai School. 2. Dr. Pongsak and persons under Section 258 hold shares in the Company and Srivichai School, representing 0.44 % of the total voting shares of the Company as of December 31, 2024. | 2024-12-31T00:00 | |
| Mongkol Vanitchapakdi | Person | 1. Holds the position of Deputy Chief Executive Officer , Member of the Remuneration and Nomination Committee, Member of the Corporate Governance and Sustainability Committee and Director of the Company, Srisakron, Yaek Faichai, and Watthanavejviwat. 2. Is the spouse of Dr. Rangsima Wanitphakdeedecha 3. Mr. Mongkol and the persons under Section 258 hold shares in the Company representing 14.79 % of the total voting shares of the Company as of December 31, 2024. | 2024-12-31T00:00 | |
| Dr. Sakda Tangjitvanichkran | Person | 1. Holds the positions of President of Finance, Member of the Finance and Investment Planning Working Group, and Director of Saiwichai, Srisakhon, and Sriwichai School. 2. Dr. Sakda and persons under Section 258 hold shares in the Company representing 0.30 percent of the total voting shares of the Company as of December 31, 2017. | 2024-12-31T00:00 | |
| Dr. Rangsima Vanichapongse | Person | 1. Holds a position on the Board of Directors of Saivichai, Yaek Faisai. 2. Is the daughter of Assoc. Prof. Dr. Nophachai and Asst. Prof. Dr. Saisunee Vanadurongvan and is the spouse of Mr. Mongkol Vanitchabhaktedecha. 3. Dr. Rangsima and the persons under Section 258 hold shares in the Company representing 14.79 percent of the total voting shares of the Company as of December 31, 2024. | 2024-12-31T00:00 | |
| Asst. Prof. Dr. Bavaret Wonduranong | Person | 1. Holds the position of Director, Member of the Finance and Investment Planning Committee, Member of the Corporate Governance and Sustainability Committee , Chairman of the Risk Management Committee and Director of Sai Wichai, and Wattanawech Wiwat. 2. Son of Assoc. Prof. Dr. Wichai and Asst. Prof. Dr. Saysunee Vondundungvan. Spouse of Dr. Teerawan Vondundungvan. 3. Mr. Bawarit and persons under Section 258 hold shares in the Company representing 16.23 percent of the total voting shares of the Company as of December 31, 2024. | 2024-12-31T00:00 | |
| Dr. Teerawan Vandurongvan | Person | 1. Holds the position of Deputy Chief Executive Officer, Member of the Corporate Governance and Sustainability Committee, Member of the Risk Management Committee and Director of Saivichai, and WatthanaVejvivat. 2. Spouse of Asst. Prof. Bowornrat Vanadurongwan, M.D. 3. Pharm.D. Teerawan and the individuals stipulated in Section 258 hold shares in the Company, representing 16.23 percent of the total voting shares of the Company as of December 31, 2024. | 2024-12-31T00:00 | |
| Prit Rojanmahamonkhol | Person | 1. Holding the position of Deputy Chief Executive Officer, Member of the Corporate Governance and Sustainability Committee,and Director of the Company, Srisakra, Yaekfaichai, and Srivichai School. 2. Spouse of Dr. Pat Rojanamahamonkhol. 3. Mr. Prut and persons under Section 258 hold shares in the Company representing 14.79 percent of the total voting shares of the Company as of December 31, 2024. | 2024-12-31T00:00 | |
| Dr. Pat Rojanamahamonkhol | Person | 1. Holds the position of Director of Sai Wichai. 2. She is the daughter of Assoc. Prof. Dr. Vichai and Asst. Prof. Dr. Saisunee Vanadurongwan and is the spouse of Mr. Prut Rojmahamongkol. 3. Dr. Pat and the persons under Section 258 hold shares in the Company, representing 14.79 percent of the total voting shares of the Company as of December 31, 2024. | 2024-12-31T00:00 | |
| Komgrit Kavinakrathiti | Person | 1. Holds the position of Advisor to the Executive Committee, Director of Sriwichai School. 2. Is the spouse of Ms. Patcharapan Vanadurongwan. 3. Mr. Komrit and persons under Section 258 hold shares in the Company representing 4.91 percent of the total voting shares of the Company as of December 31, 2024. | 2024-12-31T00:00 | |
| Ms. Patcharaphan Vandurongvan | Person | 1. Holding a position as an advisor to the Executive Board. 2. Being the daughter of Prof. Emeritus Dr. Nop. Vichai and Asst. Prof. Dr. Saisunee Vondundrungkwan and the spouse of Mr. Komgrit Gavinakrathiti. 3. Ms. Patcharaporn and the persons according to Section 258 hold shares in the Company, representing 4.91 percent of the total number of voting shares of the Company as of December 31, 2024. | 2024-12-31T00:00 |
Transactions by Counterparty
| Transactions |
|---|
| 3.15 · Necessity: The Company collects fees for medical services and treatments from Srivichai Vejvivat Public Company Limited based on the type of service provided, utilizing the mutual discount policy between the companies. · Description: Memorandum of Understanding between Srivichai Vejvivat Public Company Limited and Saivichai Development Co., Ltd. · As of yesteryear: 1.58 · Nature of transaction: Revenue from medical treatment and services: The Company's revenue from this business line is generated from referrals sent by the business line for medical treatment and services at the Company. · Audit committee opinion: The Audit Committee is of the opinion that the transactions between the Company and Saivichai are reasonable, justifiable, and in line with the Company's normal course of business. · As of year before yesteryear: 0.79 · 12.28 · Necessity: The Company collects fees for medical and healthcare services from Srivichai Vejvivat Public Company Limited based on the type of service provided, utilizing the mutual discount policy between the companies. · Description: Memorandum of Understanding between Srivichai Vejvivat Public Company Limited and Saivichai Development Co., Ltd. · As of yesteryear: 12.94 · Nature of transaction: Medical Treatment and Service Costs: Costs incurred in this section arise from the company referring its patients to receive medical treatment and services at Saivichai. · Audit committee opinion: The Audit Committee is of the opinion that the transactions between the Company and Saivichai are reasonable, justifiable, and in line with the Company's normal course of business. · As of year before yesteryear: 39.6 |
| 15.7 · Necessity: The Company collects fees for medical and healthcare services from Srivichai Vejvivat Public Company Limited based on the type of service provided, utilizing the mutual discount policy between the companies. · Description: Interim Disclosure of Srivichai Vejvivat Public Company Limited and Srisakhon Vejavivat Company Limited · As of yesteryear: 9.04 · Nature of transaction: Revenue from medical treatment and services: This revenue stems from Srisakhon sending its employees to receive medical treatment and services at the company. · Audit committee opinion: The Audit Committee is of the opinion that the transactions between the Company and Srisakhon are reasonable, appropriate, and in the ordinary course of business of the Company and Srisakhon . · As of year before yesteryear: 15.79 · 12.68 · Necessity: The Company collects fees for medical services and treatments from Srisakhon based on the type of service provided, utilizing the mutual discount policy of Srivichai Vejvivat Public Company Limited. · Description: Interim Disclosure of Srivichaivej Public Company Limited and Srisakhon Vejavivat Company Limited · As of yesteryear: 2.05 · Nature of transaction: Medical Treatment and Service Costs: Costs incurred in this section are from Srisakhon sending its patients to receive medical treatment and services at the company. · Audit committee opinion: The Audit Committee is of the opinion that the transactions between the Company and Srisakhon are reasonable, justifiable, and in the ordinary course of business of both the Company and Srisakhon. · As of year before yesteryear: 28.09 |
| 0.11 · Necessity: The Company charges medical and nursing service fees from Yaek Fai Chai Intersection, depending on the type of service, using the mutual discount policy of Srivichai Vejvivat Public Company Limited. · Description: Related transactions between Srivichai Vejvivat Public Company Limited and Bangkok Orthopedic Hospital Co., Ltd. · As of yesteryear: 0.17 · Nature of transaction: Revenue from medical treatment and services: This revenue stems from Yaek Fai Chai sending its employees to receive medical treatment and services at the company. · Audit committee opinion: The Audit Committee is of the opinion that the transactions between the Company and Yaek Fai Chai are reasonable and are normal business transactions of the Company and Yaek Fai Chai. · As of year before yesteryear: 0.31 · 1.84 · Necessity: The Company collects fees for medical and hospital services from Yaek Fai Chai, based on the type of service provided, using the mutual discount policy of Srivichai Vejvivat Public Company Limited. · Description: Memorandum of Understanding between Srivichai Vejvivat Public Company Limited and Bangkok Orthopedic Hospital Co., Ltd. · As of yesteryear: 1.16 · Nature of transaction: Cost of medical treatment and medical services: The costs incurred in this section are caused by the fact that Yaek Fai Chai sends its patients to receive medical treatment and medical services at Yaek Fai Chai. · Audit committee opinion: The Audit Committee is of the opinion that the transactions between the Company and Yaek Fai Chai are reasonable and are normal business transactions of the Company and Yaek Fai Chai. · As of year before yesteryear: 1.14 · 0.0 · Necessity: It is a reasonable list that benefits the Yaek Fai Chai business. · Description: Memorandum of Understanding between Srivichai Vejvivat Public Company Limited and Bangkok Orthopedic Hospital Co., Ltd. · As of yesteryear: 17.0 · Nature of transaction: Investment Property In 2022, the Company entered into a lease agreement for the land and buildings, 2 commercial buildings, No. 240/98-99 Charansanitwong Road, Ban Chang Lo Subdistrict, Bang Khun Non District, Bangkok, for use in hospital operations, with a lease term of 3 years, starting from November 1, 2022 to July 31, 2025, at a rental rate of 46,400 baht per month. · Audit committee opinion: The Board of Directors acknowledged that the list is reasonable, justifiable, and beneficial to the operations of the Yaek Fai Chai. · As of year before yesteryear: 17.0 · 0.77 · Necessity: It is a reasonable and beneficial list for the operation of the Yaek Fai Chai business. · Description: It is a transaction between Srivichai Vejvivat Public Company Limited and Bangkok Orthopedic Hospital Co., Ltd. · As of yesteryear: 0.47 · Nature of transaction: Commercial building rental income 2022 The Company entered into a contract to lease land and buildings, 2 commercial buildings, No. 240/98-99 Charansanitwong Road, Ban Chang Lo Subdistrict, Bang Khun Non District, Bangkok, for use in hospital operations, with a rental period of 3 years, starting from November 1, 2022 to July 31, 2025, at a rental rate of 46,400 baht per month. Later in 2024, the Company changed the lease contract for land and commercial buildings from 2 units to 6 units, No. 240/93, 240/95-99 Charansanitwong Road, Ban Chang Lo Subdistrict, Bang Khun Non District, Bangkok, for use in hospital operations. The lease term is 3 years, starting from January 1, 2024 to December 31, 2027, at a monthly rental rate of 130,200 baht after deducting a discount of 110,670 baht per month, resulting in the Company having rental income and interest income from the sub-lease contract. · Audit committee opinion: The Audit Committee is of the opinion that the transaction is reasonable and beneficial to the operations of Yaek Fai Chai. · As of year before yesteryear: 0.18 |
| 0.24 · Necessity: The Company leases a portion of the 7th floor of Building 1, at Vichaivej Omnoi Hospital , with an approximate area of 50 square meters, to Srivichai School for use as its own office space. The lease agreement is clearly established in writing and includes standard commercial lease terms. · Description: Memorandum of Understanding between rivichai Vejvivat Public Company Limited and Srivichai Vocational School Company Limited · As of yesteryear: 0.24 · Nature of transaction: The Company leases out a portion of the 7th floor of Building 1 of Vichaivej Omnoi Hospital with an area of approximately 218 square meters to Srivichai School for use as office space. The Company charges a monthly rental fee of 20,000 baht. The lease agreement between the Company and Srivichai School has a term of 3 years, commencing on March 1, 2019, and ending on December 31, 2021. The lease agreement has been renewed for another 3 years, commencing on January 1, 2022, and ending on December 31, 2024. · Audit committee opinion: The Audit Committee has reviewed the lease agreement whereby the Company leased a portion of the 7th floor of Building 1 at Vichaivej Hospital Omnoi, with an area of approximately 50 square meters, to Srivichai School. The lease agreement is for the school's own use. The lease agreement is in writing, with clear and standard commercial terms. The transaction is reasonable and beneficial to the overall operation of Vichaivej Hospital Group's private hospital business. Srivichai School was established to focus on producing nursing assistants. · As of year before yesteryear: 0.24 |
| 6.16 · Necessity: Srivichai collects fees for medical services and healthcare from Srisakhon based on the type of service, utilizing the mutual discount policy of Srivichai Vejvivat Public Company Limited. · Description: Memorandum of Understanding between Saivichai Development Company Limited and Srisakhon vejavivat Company Limited. · As of yesteryear: 15.64 · Nature of transaction: Revenue from medical treatment and services: This revenue is generated from Srisakhon sending its patients to receive medical treatment and services at Saivichai. · Audit committee opinion: The Board of Directors acknowledged that the transactions between Srivichai and Srisakhon were reasonable, justifiable, and considered normal business practices for both companies. · As of year before yesteryear: 15.64 · 0.75 · Necessity: Srivichai collects fees for medical services and healthcare from Srisakhon based on the type of service, utilizing the mutual discount policy of Srivichai Vejvivat Public Company Limited. · Description: Memorandum of Understanding between Saivichai Development Company Limited and Srisakhon vejavivat Company Limited · As of yesteryear: 0.86 · Nature of transaction: Medical Treatment and Healthcare Service Costs: These costs arise from the department sending its employees to receive medical treatment and healthcare services at Srisakhon . · Audit committee opinion: The Board of Directors acknowledged that the transactions between Saivichai andSrisakhon were reasonable, justifiable, and considered normal business practices for both companies. · As of year before yesteryear: 0.25 |
| 0.55 · Necessity: Srivichai Vejvivat Public Company Limited collects fees for medical and healthcare services based on the type of service provided, using the company's reciprocal discount policy. · Description: Interim List of Saivichai Development Company Limited and Bangkok Orthopedic Hospital Company Limited · As of yesteryear: 0.0 · Nature of transaction: Revenue from medical treatment and services: Revenue generated in this segment comes from patients referred by Yeak Fai Chai to receive medical treatment at Saivichai. · Audit committee opinion: The Board of Directors acknowledged that the transactions between the two companies were justifiable, reasonable, and considered normal business practices for both Saivichai and Yeak Fai Chai. · As of year before yesteryear: 21.84 · 0.39 · Necessity: By Saivichai paying the price of medical services and treatment to Yeak Fai Chai depending on the type of service using the mutual discount policy of Srivichai Vejvivat Public Company Limited. · Description: Memorandum of Understanding between Saivichai Development Company Limited and Bangkok Orthopedic Hospital Company Limited · As of yesteryear: 1.1 · Nature of transaction: Medical Treatment and Service Costs: Costs incurred in this section stem from the department sending its patients to receive medical treatment at Yeak Fai Chai . · Audit committee opinion: The Audit Committee is of the opinion that the transactions between the two companies are reasonable, justifiable, and are normal business transactions for both Saivichai and Yaek Faisai. · As of year before yesteryear: 10.41 |
| 4.15 · Necessity: It is a reasonable and beneficial program for the business operations of Watthana Vejvivat Company Limited. · Description: Memorandum of Understanding between Saivichai Development Company Limited and Watthana Vejvivat Company Limited · As of yesteryear: 0.0 · Nature of transaction: Revenue from Land Sales Revenue generated by Saivichai in this segment is from land sales to Wattanavejvivat. · Audit committee opinion: The Audit Committee is of the opinion that the transaction is reasonable and beneficial to the business operations of Watthana Vejvivat Company Limited · As of year before yesteryear: 0.0 |
| 1.03 · Necessity: Srisakorn charges for medical and healthcare services from Yaek Fai Chai based on the type of service provided, using the mutual discount policy of Srivichaivejvivat Public Company Limited. · Description: Memorandum of Understanding between Srisakhon vejavivat Company Limited and Bangkok Orthopedic Hospital Company Limited · As of yesteryear: 0.34 · Nature of transaction: Revenue from Medical Treatment and Services: Revenue generated in this segment is attributed to referrals from Yaek Fai Chai Hospital, with patients seeking medical treatment and healthcare services at Srisakhon . · Audit committee opinion: The Board of Directors acknowledged that the transactions between the two companies were justifiable, reasonable, and considered normal business operations for both Srisakhon and Yaek Fai Chai · As of year before yesteryear: 3.53 · 75.0 · Necessity: The spin-off of Bangkok Orthopedic Hospital Company Limited is a reasonable and beneficial endeavor. It will benefit the company's private hospital business and the overall Vichaivej Hospital Group. Additionally, obtaining loans will involve a less complicated process, requiring less time compared to borrowing from external financial institutions. The loan conditions will also be less cumbersome. · Description: Memorandum of Understanding between Srisakhon vejavivat Company Limited and Bangkok Orthopedic Hospital Company Limited · As of yesteryear: 0.0 · Nature of transaction: Short-term loan: In 2024, the Company provided a short-term loan of 75 million baht to Bangkok Orthopedic Hospital Company Limited at an interest rate of 3% per annum. The loan is repayable on demand, unsecured, and granted to Bangkok Orthopedic Hospital Company Limited for business operations. · Audit committee opinion: The Board of Directors acknowledged the company's provision of short-term loans to the company through the issuance of promissory notes payable on demand. · As of year before yesteryear: 0.0 · 0.02 · Necessity: Srisakhon charges for medical and healthcare services provided by Yaek Fai Chai based on the type of service, using the mutual discount policy of Srivichai Vejvivat Public Company Limited. · Description: Memorandum of Understanding between Srisakhon vejavivat Company Limited and Bangkok Orthopedic Hospital Company Limited · As of yesteryear: 0.04 · Nature of transaction: Medical care and service costs: Costs incurred in this section are due to Srisakhon sending its patients to receive medical care and services at Yaek Fai Chai . · Audit committee opinion: The Board of Directors acknowledged that the transactions between the two companies were justifiable, reasonable, and considered normal business operations for both Srisakhon and Yaek Fai Chai. · As of year before yesteryear: 0.81 |
| 5.1 · Necessity: The rental fee for the Yaek Fai Chai separator, as per the lease agreement, is reasonable and beneficial to the Yaek Fai Chai separator's business operations. The key conditions stipulated in the letter of consent for the use of the building and premises are reasonable and customary in accordance with general commercial terms. · Description: Related transactions of Bangkok Orthopedic Hospital Company Limited and Mrs. Rangsima Wanichphakdidecha ("Mrs. Rangsima") Mrs. Pat Rojanamahamongkol ("Mrs. Pat") and Mr. Bowonrat Wanadurongwan ("Mr. Bowonrat") · As of yesteryear: 6.8 · Nature of transaction: Non-Current Assets - Right-of-Use Assets In 2016, Yaek Fai Chai entered into a lease agreement for land and buildings with Ms. Rangsima, Ms. Pat, and Mr. Bawarat to use 5 shophouses, located at 240/1 to 240/4 and 240/8 Charansanitwong Road, Bang Khun Sri Subdistrict, Bangkok Noi District, Bangkok, which are the properties of Ms. Rangsima, Ms. Pat, and Mr. Bawarat. Yaek Fai Chai uses the said area for the purpose of operating an outpatient clinic, patient ward, and critical care unit. The agreed upon rental payments to the lessor are as follows: 1) Lump sum payment of 3.60 million baht 2) From January 1, 2016 to December 31, 2017, a monthly rent of 0.13 million baht 3) From January 1, 2018 to December 31, 2020, a monthly rent of 0.15 million baht 4) From January 1, 2021 to December 31, 2023, a monthly rent of 0.16 million baht 5) From January 1, 2024 to December 31, 2026, a monthly rent of 0.18 million baht · Audit committee opinion: The Audit Committee is of the opinion that the lease agreement for land and buildings entered into by Yaek Fai Chai with Ms. Rangsima, Ms. Pat, and Mr. Bawarit, for the use of 5 buildings, namely house numbers 240/1 to 240/4 and 240/8, Charansanitwong Road, Bangkhun Sri, Bangkhok Noi, Bangkok, which are the properties of Ms. Rangsima, Ms. Pat, and Mr. Bawarit, is for Yaek Fai Chai to utilize the said area for the purpose of conducting business related to an outpatient building, patient ward, and critical care unit. · As of year before yesteryear: 8.5 |

